RSIP Vision: An Innovative Set of AI Modules for Enhanced Medical Ultrasound Applications is Introduced

June 22, 2020

RSIP Vision has announced a new set of AI-based medical ultrasound modules.

RSIP Vision notes these advanced modules will serve as AI-based building blocks for a variety of applications, ranging from automated diagnosis, measurement, and volume estimation, to advanced procedure planning and in-op guided tracking.

When integrated into third-party ultrasound carts, PACS systems, and proprietary cloud platforms, these modules will enable a new set of innovative capabilities in a wide range of domains, such as urology, OBGYN, general imaging, cardiac procedures, and more.

These new building blocks will enable new applications, including:

Biopsy guidance – The modules allow for real-time, AI-guided needle biopsy procedures, while providing an improved understanding of the lesion or mass. They utilize automated tissue segmentation capabilities, clearly separate the abnormal tissue from the healthy one, and provide the surgeon with all the necessary data required to get to the desired area quickly and precisely.

Automated measurements and function evaluation in Cardiac Ultrasound – These AI modules perform fully automated segmentation of the heart chambers from different ultrasound views, which automates the most important measurements, such as Ejection Fraction, CO, EDA, and EDA. It also evaluates the performance of main heart functions, such as motion of the valves and walls, and detects and classifies abnormalities.

3D Reconstruction – In many cases, the sonographer will be able to demonstrate only a few slices of the organ at focus. The reconstruction function can build the complete organ from sparse information and help the interventional surgeon navigate accurately for biopsy or ablation procedures.

Patient Screening – Integrated into cloud-based settings, these AI capabilities can perform automated analysis of ongoing ultrasound studies, provide triage and second-opinion analysis, detect irregularities and potential errors, prioritize workflow, and boost population healthcare management capabilities.

“Ultrasound is extremely user-dependent and can be challenging to interpret. These innovative AI modules help medical teams make quick and accurate clinical decisions and lower the dependence on teams’ experience,” says Dr. Rabeeh Fares, Radiologist; Department of Diagnostic Radiology, Sourasky Medical Center, Tel Aviv, Israel.

The usage of ultrasound imaging plays a crucial role in the diagnosis and treatment of many pathologies. Its wide availability and relatively low cost, with no radiation considerations, makes it the preferred imaging modality across a number of clinical fields. It can immediately detect pathologies and injuries across the entire healthcare pathway and is useful in a variety of settings, from ER triage and intensive care units to point-of-care settings and outpatient clinics.

Hot this week

Cartessa Aesthetics Partners with Classys to Bring EVERESSE to the U.S. Market

Classys, which is listed on the KOSDAQ, is one of South Korea's most distinguished aesthetic technology manufacturers, with devices distributed in 80+ markets globally. This partnership marks Classys's official entry into the American marketplace, with Cartessa Aesthetics as the exclusive distributor for EVERESSE, launched under the Volnewmer brand in current global markets.

Stryker Launches Next-Generation of SurgiCount+

Now integrated with Stryker's Triton technology, SurgiCount+ addresses two key challenges: retained surgical sponges and blood loss assessment. Integrating these previously separate digital solutions provides the added benefit of a more efficient, streamlined workflow for hospitals notes Stryker.

Nevro Receives CE Mark In Europe for It’s HFX iQ™ Spinal Cord Stimulation System

Nevro notes HFX iQ is the first and only SCS system with artificial intelligence (AI) technology that combines high-frequency (10 kHz) therapy built on landmark evidence that uses ongoing cloud data insights to deliver personalized pain relief

Recor Medical Reports: CMS Grants Distinct TPT Device Code and Category to Recor Medical for Ultrasound Renal Denervation

The approval of TPT offers incremental reimbursement payments for outpatient procedures performed with ultrasound renal denervation for Medicare fee-for-service beneficiaries. It becomes effective January 1, 2025, and is expected to remain effective for up to three years notes Recor Medical.

Jupiter Endovascular Reports | 1st U.S. Patient Treated with Jupiter Shape-shifting Thrombectomy Device

“Navigation challenges during endovascular procedures are often underappreciated and have led to under-adoption of life-saving procedures, such as pulmonary embolectomy. We have purpose-built our Endoportal Control technology to solve these issues and make important endovascular procedures accessible to more clinicians and their patients who can benefit from them,” said Carl J. St. Bernard, Jupiter Endovascular CEO. “This first case in the U.S. could not have gone better, and appears to validate the safety and performance we are seeing in our currently-enrolling European SPIRARE I study.”
Exit mobile version